Abstract:ObjectiveTo observe the blood glucose of non-newly diagnosed type 2 diabetes after of short-term intensive insulin therapy with insulin pump and to analyze the factors affecting blood glucose control.Methods190 of eligible patients with type 2 diabetes were randomly divided into observation group and control group. The observation group was given 14 days of intensive insulin therapy with insulin pump and replaced by a premixed insulin therapy, while the control group was given premixed insulin therapy. The patients were followed up for 3 months and compared for blood glucose, glycosylated hemoglobin (HbA1c), fasting C-peptide (FCP) and other indicators, to analyze the baseline factors affecting blood glucose control.Results(1)Compared to the control group, fasting plasma glucose (FPG), 2 h postprandial glucose, HbA1c were significantly reduced while FCP was obviously increased in the observation group after therapy, and the differences were statistically significant (P<0.01). In the observation group, FPG, 2 h postprandial glucose and HbA1c were significantly reduced while FCP was obviously increased after treatment, the differences were statistically significant (P<0.01). (2)Rate of blood glucose control (HbA1c<7.0%) was 35.6% in the observation group while only 26.2% in the control group. By comparing baseline characteristics of patients with (HbA1c<7.0%) and without (HbA1c≥7.0%) blood glucose control in observation group and control group, there were significant differences in diabetic duration, FPG, 2 h postprandial glucose, HbA1c and FCP (P<0.05), but no significant differences in gender, age and BMI (P>0.05). (3)Logistic regression analysis showed that the main baseline factors affecting blood glucose control of observation group included, HbA1c and FCP, with the OR values of 1.24 and 0.27, respectively.ConclusionShort-term intensive insulin therapy can improve the rate of blood glucose control after 3 months in non-newly diagnosed type 2 diabetes patients, and the effects are significantly better than the control group. HbA1c and FCP are main baseline factors affecting blood glucose control.

Insulin pump therapy for type 2 diabetes clinical curative effects analysis of pulmonary infection

Clinical observation and nursing care on patients with type 2 diabetes applied as continuous subcutaneous insulin infusion

The clinical efficiency of insulin pump therapy combined with Novolin 30R in patients with diabetes mellitus complicated with pulmonary infection and analysis of detection indexes

Study on the therapeutic effect of insulin pump in the treatment of type 1 diabetes

The Therapeutic Effect of the Insulin Pump Intensive Therapy of Newly-Diagnosed Type 2 Diabetes Mellitus(T2DM) Patients

Effect of short-term intensive insulin pump treatment on related indexes of patients with early type 2 diabetes mellitus

Efficacy Observation of the Intensivetherapy of Short-acting Insulin for 32 Patients with Type 2 Diabetes

Effect of regular intensive therapy with insulin pump on beta cell function in newly diagnosed type 2 diabetes mellitus

The Effect of Simulating Insulin Pump with Insulin Lispro and Insulin Glargine on Diabetic Patients

Impact of short-term insulin pump-intensified therapy on new type 2diabetic patients

Comparison of the efficacy between short term intensive therapy by insulin pump and multiple subcutaneous insulin injections

The Application of Insulin Pump in Diabetic Patients

Clinical Observation on Effect of Insulinpump During Perioperation of Diabetics Patient

Curative effects of insulin pump for 40 cases of type 2 diabetes mellitus during the perioperative period

[Effect of Short-Term Intensive Treatment with Insulin Pump on Beta Cell Function and the Mechanism of Oxidative Stress in Newly Diagnosed Type 2 Diabetic Patients].

Effects of Short-term Insulin Pump Intensive Treatment on Metabolism of Glucose and Lipid in Newly Diagnosed Type 2 Diabetic Patients

Clinical Study of Blood Glucose Control Treated with Insulin Pump During Perioperative Period in Type 2 Diabetes Patients

Influence factors of glucose control of intensive insulin therapy with insulin pump in non-newly diagnosed type 2 diabetes

Effect of insulin pump infusion therapy on beta cell of islet function in newly diagnosed type 2 diabetes

Study on clinical treatment effects on pulmonary infections in patients with diabetes secondary to rheumatoid arthritis

Effect of treating hyperglycemia of type 2 diabetes with continuous subcutaneous insulin infusion